H. Lundbeck A
HLUN | XCSE
Overview
Corporate Details
- ISIN(s):
- DK0061804697 (+5 more)
- LEI:
- 5493006R4KC2OI5D3470
- Country:
- Denmark
- Address:
- Ottiliavej 9, 2500 Valby
- Website:
- https://www.lundbeck.com/global
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries. We are tirelessly dedicated to restoring brain health, so every person can be their best. Research into the brain costs more, takes longer and fails at a higher rate than most other medical research. But with brain disorders sharply on the increase, it’s more important than ever. We are one of the only global pharmaceutical companies solely focused on the brain, and our research programs tackle some of the most complex challenges in neuroscience. Our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-02-21 13:27 |
Related Party Transactions
|
English | 124.1 KB | |
2025-02-21 13:27 |
Related Party Transactions
|
English | 29.9 KB | |
2025-02-05 16:40 |
Related Party Transactions
|
English | 134.1 KB | |
2025-02-05 16:40 |
Related Party Transactions
|
English | 96.6 KB | |
2025-02-05 07:46 |
Annual Report
|
English | 6.4 MB | |
2025-02-05 07:46 |
Annual Report
|
English | 2.9 KB | |
2025-02-05 07:46 |
Annual Report (ESEF)
|
English | 13.1 MB | |
2025-02-05 07:24 |
Annual Report
|
English | 33.3 KB | |
2025-02-05 07:24 |
Earnings Release
|
English | 443.0 KB | |
2025-02-04 17:11 |
Inside Information Statement
|
English | 17.0 KB | |
2025-02-04 17:11 |
Inside Information Statement
|
English | 99.1 KB | |
2025-01-09 14:07 |
Inside Information Statement
|
English | 29.4 KB | |
2025-01-09 14:07 |
Inside Information Statement
|
English | 95.4 KB | |
2024-11-28 07:56 |
Inside Information Statement
|
English | 114.8 KB | |
2024-10-31 12:44 |
Earnings Release
|
English | 30.0 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP |